YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
4:20pm: Tariff concerns linger Wall Street finished Monday on a mixed note, with renewed weakness in technology and semiconductor stocks pulling the Nasdaq and S&P 500 lower while the Dow Jones Industrial Average managed a modest gain. The…
BOSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces quantitat…
Key Points Dauntless Investment Group bought 116,863 shares of Innoviva in an estimated trade of $2.52 million last quarter. The quarter-end position value rose by $2.74 million, reflecting both trading and price movements. The post-trade…
(RTTNews) - Tiziana Life Sciences (TLSA), a biotechnology company, on Tuesday released positive clinical data from the ongoing expanded access program for intranasal Foralumab in treating non-active secondary progressive multiple sclerosis…
Healthcare stocks rose late Tuesday afternoon, with the NYSE Healthcare Index and the State Street H PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Healthcare stocks rose Tuesday afternoon, with the NYSE Healthcare Index adding 1.1% and the State S PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
[Multiple Sclerosis written on black background with stethoscope.] Md Saiful Islam Khan Tiziana Life Sciences (TLSA [https://seekingalpha.com/symbol/TLSA]) announced on Tuesday that new data from a study for an intranasal version of its le…
4:20pm: S&P 500 retreats for third straight session Stocks closed lower for a third straight session on Tuesday as rising Treasury yields and lingering inflation concerns continued to pressure equities, pulling the major indexes further aw…
BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the publ…
(RTTNews) - Tiziana Life Sciences, Ltd. (TLSA) announced that its open-label clinical study of intranasal foralumab in non-active secondary progressive multiple sclerosis has now been peer-reviewed and published, underscoring the therapy's…
BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the closi…
* Tiziana Life Sciences (TLSA [https://seekingalpha.com/symbol/TLSA]) priced [https://seekingalpha.com/pr/20367108-tiziana-life-sciences-announces-registered-direct-offering-of-up-to-approximately-17_6] a best-efforts registered direct off…
(RTTNews) - Biotech and healthcare names were among the notable movers in Wednesday's after-hours trading session, with several small-cap companies posting strong gains on the back of corporate updates and investor momentum. Plus Therapeut…
Tiziana Life Sciences Ltd. Tiziana reports excellent safety profile with intranasal foralumab after 37.4 patient-years cumulative exposure FDA denial of Sanofi’s tolebrutinib for nrSPMS shows need for safe therapy BOSTON, Dec. 29, 2025 (GL…
Tiziana reports excellent safety profile with intranasal foralumab after 37.4 patient-years cumulative exposureFDA denial of Sanofi’s tolebrutinib for nrSPMS shows need for safe therapy BOSTON, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Tiziana Lif…
BOSTON, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal f…
First Patient Expected to be Dosed Next Week with Intranasal ForalumabPET Scan Shows Presence of Untreated Neuroinflammation in Alzheimer’s Patient on Leqembi® (Lecanemab) Anti-Amyloid Therapy BOSTON, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Tizi…
(RTTNews) - Tiziana Life Sciences (TLSA) announced that it intends to develop its fully human anti-IL-6 receptor monoclonal antibody, TZLS-501, and related assets via a spinout into a separate publicly traded company. The company said Tizi…
Tiziana Life Sciences Ltd. BOSTON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that…
BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that its Phase 2 clinical trial…
Major stock indexes in the United States have mostly risen, with investors eagerly anticipating Nvidia's earnings report, which could influence broader market trends. Though the term 'penny stock' might sound like a relic of past trading d…
BOSTON, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal f…
Glass Lewis, which makes recommendations to investors about how they should vote on company proposals, has joined Institutional Shareholder Services in suggesting that Tesla shareholders reject Musk’s proposed $1 trillion compensation plan…
Tiziana Life Sciences Ltd. BOSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), today announces it will advance its second asset, a fully human anti-IL-6 receptor (“IL-6R”) mon…
In this article, we will be taking a look at the 15 Best Biotech Penny Stocks to Invest in Right Now. Tiziana Life Sciences Ltd is one of them. Tiziana Life Sciences Ltd (NASDAQ:TLSA) is a clinical-stage biotech company focused on next-gen…
BOSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal…
BOSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal…
* Tiziana Life Sciences (NASDAQ:TLSA [https://seekingalpha.com/symbol/TLSA]) rose in premarket trading after the company said Executive Chairman and Founder Gabriele Cerrone purchased 25,000 common shares at $1.60 each. * The purchase brin…
BOSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal…
BOSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal f…
[Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research. Working on Computers, Analyzing Samples] gorodenkoff/iStock via Getty Images *…
In the last week, the U.S. market has been flat, but it has shown a 14% increase over the past year, with earnings projected to grow by 15% annually. Penny stocks may be a throwback term, yet they remain relevant for investors seeking oppo…
[Moscow, Russia - April 7, 2019: NVIDIA video chip on the motherboard] Antonio Bordunovi _Seeking Alpha's daily roundup of statements and remarks that could impact the technology sector._ * OpenAI and Elon Musk are advising investors that…
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal…
[Laptop computer stand on wooden meeting table] BongkarnThanyakij/iStock via Getty Images * Tiziana Life Sciences (NASDAQ:TLSA [https://seekingalpha.com/symbol/TLSA]) shares rose on Friday after the company said that its CEO, Ivor Elrifi,…
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal…